{"id":3176,"date":"2022-05-11T14:57:22","date_gmt":"2022-05-11T13:57:22","guid":{"rendered":"https:\/\/www.touchmedicalmedia.com\/?p=3176"},"modified":"2022-05-11T14:57:22","modified_gmt":"2022-05-11T13:57:22","slug":"announcing-our-new-partnership-with-ucare-ga2len","status":"publish","type":"post","link":"https:\/\/www.touchmedicalmedia.com\/news\/announcing-our-new-partnership-with-ucare-ga2len\/","title":{"rendered":"Announcing our new partnership with UCARE\/GA2LEN!"},"content":{"rendered":"

\"\"<\/p>\n

touchRESPIRATORY and touchIMMUNOLOGY announces a new partnership with Urticaria Centers of Reference and Excellence (UCARE) and Global Allergy and Asthma European Network (GA\u00b2LEN)<\/p>\n

\n

GA\u00b2LEN, the Global Allergy and Asthma European Network, has recently launched a programme for the development, interaction and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centres of excellence. The first area chosen is urticaria.<\/p>\n

Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard to treat conditions such as urticaria. The main aims of GA\u00b2LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities.<\/p>\n

For more information about UCARE\/GA2LEN click\u00a0here<\/a><\/span><\/p>\n

Take a look at our content regarding:<\/p>\n

Dermatological conditions<\/a><\/span>\u00a0(touchIMMUNOLOGY)<\/p>\n

Allergy content<\/a><\/span>\u00a0(touchRESPIRATORY)<\/p>\n<\/div>\n

\n
\n

Sign up to today to receive updates in your inbox for new content and congress highlights from<\/p>\n